Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data
This study identified IL2RG, HOXD10, and TSPAN1 as novel potential molecular markers for CASL, providing valuable biological evidence for the diagnosis and intervention of CASL.
Authors
- Yuguang Sun (ORCID: https://orcid.org/0000-0002-9441-7549)
- Peilin Li (ORCID: https://orcid.org/0000-0002-9136-0882)
- Jianliang Miao
- Zhong Liu
- Song Xia (ORCID: https://orcid.org/0000-0001-7997-0795)
- Wenbin Shen
- Hao Dong
Institutions
- Dalian Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Beijing Shijitan Hospital (CN)
- Institute of Clinical and Experimental Lymphology (RU)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-13
- DOI
- https://doi.org/10.3389/fonc.2026.1760040
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00